154 related articles for article (PubMed ID: 11916910)
1. Indinavir induces acute and reversible peripheral insulin resistance in rats.
Hruz PW; Murata H; Qiu H; Mueckler M
Diabetes; 2002 Apr; 51(4):937-42. PubMed ID: 11916910
[TBL] [Abstract][Full Text] [Related]
2. The HIV protease inhibitor indinavir decreases insulin- and contraction-stimulated glucose transport in skeletal muscle.
Nolte LA; Yarasheski KE; Kawanaka K; Fisher J; Le N; Holloszy JO
Diabetes; 2001 Jun; 50(6):1397-401. PubMed ID: 11375341
[TBL] [Abstract][Full Text] [Related]
3. Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations.
Murata H; Hruz PW; Mueckler M
AIDS; 2002 Apr; 16(6):859-63. PubMed ID: 11919487
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of insulin resistance caused by HIV protease inhibitor therapy.
Murata H; Hruz PW; Mueckler M
J Biol Chem; 2000 Jul; 275(27):20251-4. PubMed ID: 10806189
[TBL] [Abstract][Full Text] [Related]
5. A structural basis for the acute effects of HIV protease inhibitors on GLUT4 intrinsic activity.
Hertel J; Struthers H; Horj CB; Hruz PW
J Biol Chem; 2004 Dec; 279(53):55147-52. PubMed ID: 15496402
[TBL] [Abstract][Full Text] [Related]
6. Insulin sensitivity is preserved despite disrupted endothelial function.
Shankar SS; Considine RV; Gorski JC; Steinberg HO
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E691-6. PubMed ID: 16705064
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo prevention of HIV protease inhibitor-induced insulin resistance by a novel small molecule insulin receptor activator.
Cheng M; Chen S; Schow SR; Manchem VP; Spevak WR; Cristobal CP; Shi S; Macsata RW; Lum RT; Goldfine ID; Keck JG
J Cell Biochem; 2004 Aug; 92(6):1234-45. PubMed ID: 15258906
[TBL] [Abstract][Full Text] [Related]
8. Indinavir uncovers different contributions of GLUT4 and GLUT1 towards glucose uptake in muscle and fat cells and tissues.
Rudich A; Konrad D; Török D; Ben-Romano R; Huang C; Niu W; Garg RR; Wijesekara N; Germinario RJ; Bilan PJ; Klip A
Diabetologia; 2003 May; 46(5):649-58. PubMed ID: 12712244
[TBL] [Abstract][Full Text] [Related]
9. Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study.
Noor MA; Seneviratne T; Aweeka FT; Lo JC; Schwarz JM; Mulligan K; Schambelan M; Grunfeld C
AIDS; 2002 Mar; 16(5):F1-8. PubMed ID: 11964551
[TBL] [Abstract][Full Text] [Related]
10. HIV protease inhibitors acutely impair glucose-stimulated insulin release.
Koster JC; Remedi MS; Qiu H; Nichols CG; Hruz PW
Diabetes; 2003 Jul; 52(7):1695-1700. PubMed ID: 12829635
[TBL] [Abstract][Full Text] [Related]
11. HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus.
Carper MJ; Cade WT; Cam M; Zhang S; Shalev A; Yarasheski KE; Ramanadham S
Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E558-67. PubMed ID: 18171911
[TBL] [Abstract][Full Text] [Related]
12. Time courses of changes in hepatic and skeletal muscle insulin action and GLUT4 protein in skeletal muscle after STZ injection.
Youn JH; Kim JK; Buchanan TA
Diabetes; 1994 Apr; 43(4):564-71. PubMed ID: 8138062
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of indinavir in healthy HIV-seronegative men.
Noor MA; Lo JC; Mulligan K; Schwarz JM; Halvorsen RA; Schambelan M; Grunfeld C
AIDS; 2001 May; 15(7):F11-8. PubMed ID: 11399973
[TBL] [Abstract][Full Text] [Related]
14. Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.
Rossetti L; Stenbit AE; Chen W; Hu M; Barzilai N; Katz EB; Charron MJ
J Clin Invest; 1997 Oct; 100(7):1831-9. PubMed ID: 9312184
[TBL] [Abstract][Full Text] [Related]
15. Effect of magnesium sulfate administration to improve insulin resistance in type 2 diabetes animal model: using the hyperinsulinemic-euglycemic clamp technique.
Sohrabipour S; Sharifi MR; Sharifi M; Talebi A; Soltani N
Fundam Clin Pharmacol; 2018 Dec; 32(6):603-616. PubMed ID: 29869808
[TBL] [Abstract][Full Text] [Related]
16. Indinavir increases glucose production in healthy HIV-negative men.
Schwarz JM; Lee GA; Park S; Noor MA; Lee J; Wen M; Lo JC; Mulligan K; Schambelan M; Grunfeld C
AIDS; 2004 Sep; 18(13):1852-4. PubMed ID: 15316349
[TBL] [Abstract][Full Text] [Related]
17. Involvement of non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats.
Guillaume-Gentil C; Assimacopoulos-Jeannet F; Jeanrenaud B
Diabetologia; 1993 Oct; 36(10):899-906. PubMed ID: 8243867
[TBL] [Abstract][Full Text] [Related]
18. Need for GLUT4 activation to reach maximum effect of insulin-mediated glucose uptake in brown adipocytes isolated from GLUT4myc-expressing mice.
Konrad D; Bilan PJ; Nawaz Z; Sweeney G; Niu W; Liu Z; Antonescu CN; Rudich A; Klip A
Diabetes; 2002 Sep; 51(9):2719-26. PubMed ID: 12196464
[TBL] [Abstract][Full Text] [Related]
19. Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats.
Kim JK; Wi JK; Youn JH
Diabetes; 1996 Apr; 45(4):446-53. PubMed ID: 8603766
[TBL] [Abstract][Full Text] [Related]
20. GS-8374, a novel HIV protease inhibitor, does not alter glucose homeostasis in cultured adipocytes or in a healthy-rodent model system.
Hruz PW; Yan Q; Tsai L; Koster J; Xu L; Cihlar T; Callebaut C
Antimicrob Agents Chemother; 2011 Apr; 55(4):1377-82. PubMed ID: 21245443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
